Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Pascoe (Collegeville, PA, United States of America), N. Barnes (Brentford, United Kingdom), G. Brusselle (Ghent, Belgium), C. Compton (Brentford, United Kingdom), G. Criner (Philadelphia, PA, United States of America), M. Dransfield (Birmingham, AL, United States of America), D. Halpin (Exeter, United Kingdom), M. Han (Ann Arbor, Michigan, United States of America), B. Hartley (Twickenham, United Kingdom), E. Hilton (Brentford, United Kingdom), P. Lange (Copenhagen, Denmark), S. Lettis (Uxbridge, United Kingdom), D. Lipson (Collegeville; Philadeliphia, PA, United States of America), D. Lomas (London, United Kingdom), F. Martinez (New York, United States of America), A. Papi (Ferrara, Italy), N. Roche (Paris, France), R. Van Der Valk (Brentford, United Kingdom), R. Wise (Baltimore, Maryland, United States of America), D. Singh (Manchester, United Kingdom). Late Breaking Abstract - Blood eosinophil counts and treatment response in COPD: analyses of IMPACT. 2127

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Blood eosinophil count and exacerbation history in COPD: pooled analysis of 24,103 patients Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019 Late Breaking Abstract - Lack of stability of blood eosinophil counts in patients with COPD. Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 Late Breaking Abstract - Blood and bronchoalveolar neutrophil signatures associate with COPD severity Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases Year: 2021 Late Breaking Abstract - Revisiting interpretation of blood eosinophil counts (BECs): data from Brazil Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS) Source: International Congress 2018 – Eosinophils in airway disease Year: 2018 Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD? Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 Late Breaking Abstract - Association between blood eosinophils and exacerbation risk in COPD primary care Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Response to omalizumab treatment according to blood eosinophil count: Results of a French real-world study (STELLAIR) Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017 Late Breaking Abstract - Long-term variability of blood eosinophils in COPD patients by GOLD 2017 staging, and gender bias Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Late Breaking Abstract - Characterizing responders to benralizumab for severe asthma: pooled analysis of the SIROCCO and CALIMA studies Source: International Congress 2017 – Update and new perspectives in Airway Diseases Year: 2017 Late Breaking Abstract - Accelerated lung function decline in former and light smokers: NHLBI Pooled Cohorts Study Source: International Congress 2018 – Effect of environmental exposure on lung function outcomes Year: 2018 Late Breaking Abstract - Optimizing FEV1/FVC threshold to predict COPD hospitalization and mortality: NHLBI pooled cohorts study Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD? Year: 2018 Late Breaking Abstract - The blood eosinophils count as a predictor of the response for omalizumab (OMA) in patients suffering from severe allergic asthma Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 LATE-BREAKING ABSTRACT: Is Blood Eosinophil Count a Predictor of Response to Bronchodilators in COPD? Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Late Breaking Abstract - Lung deflation with Indacaterol/Glycopyrronium improves cardiac function in COPD patients: The CLAIM Study Source: International Congress 2017 – Update and new perspectives in Airway Diseases Year: 2017 Late Breaking Abstract - Benralizumab treatment strongly reduces blood basophils in patients with severe eosinophilic asthma Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Late Breaking Abstract - Blood eosinophils in inhaled steroid dose titration Source: International Congress 2017 – Towards new anti-inflammatory and anti-fibrotic agents Year: 2017 Late Breaking Abstract - Blood eosinophil count (EOS) can accurately predict responsiveness to inhaled corticosteroids (ICS) in COPD, but only if measured while patients are not receiving steroids. Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS Year: 2018 Late Breaking Abstract - Small airways dysfunction predicts asthma control and exacerbations: Longitudinal Data from  ATLANTIS Study Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Late Breaking Abstract - Blood Eosinophils as Predictor of Outcomes in hospitalized COPD Exacerbations: Results from a Prospective Study Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019